By Counterforce Health Team in Eylea / Lucentis (aflibercept / ranibizumab) —

How to Get Eylea and Lucentis Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Eylea/Lucentis Covered by Blue Cross Blue Shield in New Jersey

Blue Cross Blue Shield of New Jersey requires prior authorization for Eylea (aflibercept) and Lucentis (ranibizumab) under the medical benefit, with step therapy typically requiring bevacizumab (Avastin) first. Submit requests through the Horizon Blue Cross Blue Shield provider portal with OCT imaging, visual acuity measurements, and documentation of Avastin failure or contraindication. If denied, you have 180 days to appeal internally, followed by New Jersey's Independent Health Care Appeals Program (IHCAP) through Maximus Federal Services for external review.

First step today: Verify your specific Blue Cross Blue Shield plan type and confirm Eylea/Lucentis requires prior authorization by calling the member services number on your insurance card.

Table of Contents

  1. What This Guide Covers
  2. Before You Start: Plan Verification
  3. Gather Required Documentation
  4. Submit Your Prior Authorization Request
  5. Follow-Up and Timeline Expectations
  6. Common Denial Reasons and Solutions
  7. Appeals Process: Internal and External Review
  8. New Jersey IHCAP External Appeals
  9. Cost Savings and Patient Assistance
  10. Frequently Asked Questions

What This Guide Covers

This comprehensive guide helps patients and healthcare providers navigate Blue Cross Blue Shield prior authorization and appeals for anti-VEGF injections in New Jersey. Whether you need Eylea for wet age-related macular degeneration (AMD) or Lucentis for diabetic macular edema, this step-by-step approach can improve your chances of coverage approval.

Eylea and Lucentis are expensive treatments—often $1,200-$2,500 per injection—making insurance coverage essential for most patients. With proper documentation and persistence through New Jersey's robust appeals system, many initially denied requests can be overturned.

Before You Start: Plan Verification

Confirm Your Blue Cross Blue Shield Plan Type

Not all Blue Cross Blue Shield plans in New Jersey have identical policies. Contact member services using the number on your insurance card to verify:

  • Whether prior authorization is required for your specific plan
  • If Eylea/Lucentis are covered under medical or pharmacy benefits
  • Your plan's specific step therapy requirements
  • Any quantity or frequency limitations

Coverage at a Glance

Requirement What It Means Where to Find It
Prior Authorization Required for most BCBS NJ plans Horizon PA Search Tool
Medical Benefit Coverage Billed through provider, not pharmacy Office-Administered Specialty Medications List
Step Therapy Avastin (bevacizumab) typically required first BCBS medical policies
Appeals Deadline 180 days from denial date New Jersey insurance regulations

Gather Required Documentation

Essential Medical Records

Your ophthalmologist or retina specialist should compile:

Diagnostic Documentation:

  • OCT (Optical Coherence Tomography) showing macular edema or choroidal neovascularization
  • Fluorescein angiography results (when available)
  • Visual acuity measurements (baseline and current)
  • Complete ophthalmologic examination notes
  • ICD-10 diagnosis codes (e.g., H35.32 for wet AMD, E11.311 for diabetic macular edema)

Treatment History:

  • Documentation of prior bevacizumab (Avastin) trials with dates and outcomes
  • Records of treatment failures, lack of response, or contraindications
  • Any adverse reactions to alternative therapies
  • Previous anti-VEGF injection history from any provider

Clinician Corner: Medical Necessity Letter Checklist

Healthcare providers should include these elements in their prior authorization letter:

  • Problem statement: Specific diagnosis with severity indicators
  • Prior treatments: Detailed history of bevacizumab trials, including dates, number of injections, and objective response measures
  • Clinical rationale: Why Eylea or Lucentis is medically necessary over alternatives
  • Guideline support: Reference to FDA labeling and professional society recommendations
  • Monitoring plan: How treatment response will be assessed and documented

Submit Your Prior Authorization Request

Step-by-Step Submission Process

Step 1: Access the Horizon Blue Cross Blue Shield Provider Portal

  • Log into the provider portal
  • Search using CPT code 67028 (intravitreal injection) or HCPCS codes J2778 (Lucentis) or J3590 (Eylea)

Step 2: Complete the Prior Authorization Form

  • Download the general Prior Authorization/Pre-Service Registration form from the forms library
  • Include all required patient demographics and insurance information
  • Attach comprehensive medical documentation

Step 3: Submit Through Preferred Channel

  • Online portal (fastest processing)
  • Fax submission (verify current fax number with member services)
  • Mail submission (allow additional processing time)
Tip: Always request a confirmation receipt and reference number for tracking purposes.

Follow-Up and Timeline Expectations

Standard Processing Times

Blue Cross Blue Shield of New Jersey typically processes prior authorization requests within:

  • Standard requests: 15 business days
  • Expedited requests: 72 hours (for urgent medical situations)

When and How to Follow Up

Day 3-5: Call to confirm receipt if no confirmation received Day 10: Check status if no decision communicated Day 15: Escalate if approaching deadline without response

Sample Follow-Up Script: "I'm calling to check the status of a prior authorization request for [patient name], member ID [number], for Eylea/Lucentis injection. The reference number is [if available]. Can you provide a status update and expected decision timeline?"

Common Denial Reasons and Solutions

Denial Reason How to Address
Step therapy not met Document bevacizumab trials with dates, outcomes, and reasons for discontinuation
Insufficient medical necessity Provide OCT progression, visual acuity decline, and functional impact documentation
Missing diagnostic imaging Submit recent OCT and fluorescein angiography results
Frequency/quantity limits exceeded Justify injection schedule with clinical guidelines and response monitoring
Non-preferred agent Document contraindications or failures with preferred alternatives

Appeals Process: Internal and External Review

Internal Appeal (First Level)

If your initial request is denied:

Timeline: File within 180 days of denial notice Process: Submit written appeal with:

  • Copy of original denial letter
  • Point-by-point rebuttal addressing denial reasons
  • Updated medical records and imaging
  • Medical necessity letter from treating physician
  • Relevant clinical literature supporting treatment

Peer-to-Peer Review Option

Request a peer-to-peer discussion between your physician and Blue Cross Blue Shield's medical director:

  • Call the number provided in the denial letter
  • Prepare 3-5 key talking points about medical necessity
  • Have patient's complete medical file available
  • Document the conversation outcome and any commitments made

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Their platform can help identify the specific denial basis and draft comprehensive rebuttals that align with your plan's own coverage policies, potentially saving valuable time in the appeals process.

New Jersey IHCAP External Appeals

When Internal Appeals Are Exhausted

New Jersey offers one of the most comprehensive external review programs in the country through the Independent Health Care Appeals Program (IHCAP).

Filing with Maximus Federal Services

Eligibility: Available after completing internal appeals (or if Blue Cross Blue Shield fails to respond timely) Deadline: Within 4 months of final internal denial Cost: Free to patients and providers

IHCAP Submission Process

Online Filing (Recommended):

  1. Register at njihcap.maximus.com
  2. Upload denial letters, medical records, and consent forms
  3. Complete the application checklist
  4. Submit electronically for fastest processing

Alternative Submission Methods:

  • Mail: Maximus Federal Services, Attn: State Appeals/NJ IHCAP, 3750 Monroe Ave #705, Pittsford, NY 14534
  • Email: [email protected]
  • Expedited Fax: 585-425-5296 (urgent cases only)

IHCAP Timeline and Outcomes

  • Standard review: Decision within 45 calendar days
  • Expedited review: Decision within 48 hours for urgent cases
  • Binding decision: If IHCAP overturns the denial, Blue Cross Blue Shield must provide coverage
Note: IHCAP decisions are final and binding on both the insurance plan and the member.

Cost Savings and Patient Assistance

Manufacturer Support Programs

Regeneron (Eylea):

Genentech (Lucentis):

Additional Resources

  • Patient Access Network Foundation: Provides copay assistance for chronic disease treatments
  • NeedyMeds: Database of patient assistance programs and discount options
  • GoodRx: May offer savings for cash-pay situations (though typically not applicable for injections)

Frequently Asked Questions

How long does Blue Cross Blue Shield prior authorization take in New Jersey? Standard requests are processed within 15 business days, while expedited requests for urgent medical situations receive decisions within 72 hours.

What if Eylea or Lucentis is non-formulary on my plan? You can request a formulary exception by documenting medical necessity and failure of or contraindications to preferred alternatives. This requires the same documentation as a standard prior authorization.

Can I request an expedited appeal if my vision is deteriorating? Yes, both internal appeals and IHCAP external reviews offer expedited processing for cases where delays could cause serious harm to your vision or health.

Does step therapy apply if I've tried bevacizumab outside of New Jersey? Treatment history from any state or provider should be documented and submitted. Blue Cross Blue Shield should accept properly documented prior therapy regardless of where it occurred.

What happens if IHCAP upholds the denial? IHCAP decisions are final for the external review process. However, you may still have options through state insurance commissioner complaints or legal consultation, depending on your specific circumstances.

How often do I need to renew prior authorization? This varies by plan, but many require reauthorization every 6-12 months. Calendar renewal dates and prepare updated documentation showing continued medical necessity and treatment response.

From Our Advocates

Based on our experience helping patients navigate coverage appeals, we've found that the most successful cases include comprehensive documentation of functional vision impact—not just clinical measurements. Patients who document how vision loss affects daily activities like reading, driving, or work performance often see better outcomes in both internal and external appeals. Remember, medical necessity isn't just about meeting clinical criteria; it's about demonstrating real-world impact on quality of life.

Sources and Further Reading

For additional support with complex appeals, Counterforce Health offers specialized assistance in developing evidence-backed appeals that address payer-specific coverage criteria and procedural requirements.

Disclaimer: This guide provides educational information about insurance coverage and appeals processes. It is not medical advice and should not replace consultation with your healthcare provider or insurance plan. Coverage policies and procedures may change; always verify current requirements with your specific Blue Cross Blue Shield plan and consult with qualified professionals for personalized guidance.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.